RAGE antagonists (Mabprex)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameRAGE antagonists (Mabprex)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonists
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsDiabetic NephropathiesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabPrex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabPrex Inc
Active IndicationsN/A
Inactive IndicationsDiabetic NephropathiesAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A